Redwood City, CA, United States of America

Incline Therapeutics, Inc.


USPTO Granted Patents = 10

% Expired Patents = 90.0


Forward Citations = 28

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Corinna X Chen (9 out of 9 patents)

silverMedal Brian W Read (9 out of 10 patents)

bronzeMedal John Timothy Lemke (9 out of 12 patents)

4.  Paul G Hayter (7 out of 14 patents)

5.  Bradley E White (7 out of 14 patents)

6.  Jason E Dougherty (6 out of 6 patents)

7.  Scot Satre (4 out of 4 patents)

8.  Zita S Netzel (3 out of 7 patents)

9.  David R Seward (3 out of 15 patents)

10.  Michael Nelson (1 out of 93 patents)

11.  Nitin B Joshi (1 out of 1 patent)

12.  Paul Hayter (1 patent)


10 patents:

Company Overview
Incline Therapeutics, Inc. is a biotechnology company based in Redwood City, California, focused on developing innovative therapies for patients with unmet medical needs. The company specializes in advancing drug delivery systems and therapeutic solutions that enhance patient outcomes in various therapeutic areas. By leveraging cutting-edge research and technology, Incline Therapeutics aims to address critical challenges in treatment efficacy and safety, positioning itself as a key player in the biopharmaceutical landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

10 Patents

#152 in Redwood City, CA

#7,118 in California

#29,882 in US

#56,092 in the World

Redwood City, CA (US)
Redwood City, CA, United States of America
Forward Citations = 28

10 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Incline Therapeutics, Inc.. Retrieved from https://idiyas.com/company/incline-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…